Clin2
NCT06152991Possibly a fitEnrolling by invitation

Godex for fatty liver: a Phase 3 trial

Non-Alcoholic Fatty Liver Disease

Part of Digestive system clinical trials.

This study tests an investigational supplement called Godex Carnitine Orotate Complex to see if it helps people with nonalcoholic fatty liver disease (NAFLD) lower their liver enzymes and reduce liver fat. It may be a good option if you have elevated liver enzymes and evidence of fat in your liver.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
196 people
Ages
19 years to 74 years
Study type
Interventional

Who can take part

  • You are between 19 and 75 years old.
  • You have elevated liver enzymes (AST or ALT) on your blood tests—either 60 or more, or 40–59 for at least 3 months.
  • Your doctor finds evidence of fat in your liver (at least 7% on an MRI scan).
  • If you have diabetes, your blood sugar control is good (HbA1c under 8.5%) and your diabetes medicines haven't changed in the last 12 weeks.
  • You are willing to follow study procedures and sign a consent form.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06704321Recruiting
Effects of TOTUM-448 on liver fat and heart health

This trial tests a supplement called TOTUM-448 to see if it can reduce liver fat and improve heart health in people with a fatty liver condition (MASLD). If you have excess liver fat and are overweight, this study could help find new ways to manage your condition.

Québec, Quebec
NCT07407634Not yet recruiting· Early Phase 1
Study of an experimental tablet in healthy adults

This study tests an experimental medication called XTYW007 to see if it is safe and how it works in the body. You would take the pills under close supervision and have your health monitored.

Jilin City, Changchun
NCT06694935Recruiting· Phase 1
Testing QX1206 in type 2 diabetes with fatty liver

This trial tests a new pill called QX1206 for people who have both Type 2 diabetes and fatty liver disease (NAFLD). The goal is to see if the medicine is safe and can help improve both conditions.

Toronto
NCT06891365Recruiting· Phase 1
Multiple doses of a new drug for fatty liver disease

This trial tests a new medication for people with fatty liver disease. It will see if the drug can reduce liver fat and improve liver health over several doses.

Harrow
NCT07285135Not yet recruiting
Glycine supplement for fatty liver disease

This trial studies whether a supplement called glycine (an amino acid) can help improve fatty liver disease. It involves taking the supplement daily and doing MRI scans to see if the fat in your liver changes.

NCT06727279Not yet recruiting
Plant-based food for fatty liver disease

This trial tests special food products made from plant protein to see if they are well-tolerated and if they can improve your cholesterol and fat levels in the blood. If you have fatty liver disease, this could be a way to improve your health through diet.

Hear when a new Non-Alcoholic Fatty Liver Disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.